Global Radiation Dose Management Market Expected to Reach $960 Million

The rise in demand is largely fueled by the growing volume of medical imaging procedures and stricter regulatory requirements for tracking radiation exposure. Healthcare organizations are shifting from basic tracking software toward integrated platforms that facilitate benchmarking and automated reporting. This transition is supported by national initiatives, such as the UK Health Security Agency’s recent updates to diagnostic reference levels, which provide standardized benchmarks for hospitals to refine their internal safety protocols.

While on-premise infrastructure currently holds the largest market share due to its ease of integration with existing clinical IT systems, the industry is seeing a significant pivot toward service-oriented models. These services address the complexities of maintaining modern dose-management environments, including ongoing configuration, staff training, and data interoperability. Geographically, the Asia-Pacific region is poised to become the fastest-growing market, bolstered by rapid investments in hospital infrastructure and an increased focus on radiation protection standards across major economies like China, India, and South Korea.

The competitive landscape remains concentrated, with the top five players controlling up to 70% of the market. Recent consolidation reflects a broader trend of integrating radiation dose management with enterprise imaging and AI-driven diagnostic tools. Major acquisitions, such as GE HealthCare’s purchase of Intelerad and Sectra’s addition of Oxipit, underscore a strategic shift toward unified, AI-enabled ecosystems that prioritize both clinical efficiency and patient safety.